Discontinued — last reported Q3 '20
Becton, Dickinson and Company Medical Essentials — Goodwill decreased by 73.0% to $7.01B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 73.5%, from $26.44B to $7.01B. Over 5 years (FY 2020 to FY 2025), Medical Essentials — Goodwill shows relatively stable performance with a 1.9% CAGR.
An increase suggests recent strategic acquisitions within the segment, while a decrease usually signals an impairment charge due to underperformance or a reassessment of asset value.
This metric represents the carrying value of goodwill specifically allocated to the Medical Essentials segment, arising...
Comparable to goodwill balances in other medical device companies that have grown through M&A, reflecting the historical acquisition activity of the segment.
bdx_segment_medical_essentials_goodwill| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q3 '25 | Q4 '25 | Q4 '25 | Q1 '26 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $23.81B | $23.89B | $24.12B | $24.10B | $23.97B | $24.62B | $24.76B | $24.78B | $24.58B | $24.52B | $24.60B | $24.57B | $24.55B | $26.47B | $26.33B | $26.44B | $26.60B | $25.96B | $7.01B | $26.62B | $7.02B | $25.96B | $7.01B |
| QoQ Change | — | +0.3% | +1.0% | -0.1% | -0.5% | +2.7% | +0.6% | +0.1% | -0.8% | -0.3% | +0.3% | -0.1% | -0.1% | +7.8% | -0.5% | +0.4% | +0.6% | -2.4% | -73.0% | +279.7% | -73.6% | +270.0% | -73.0% |
| YoY Change | — | — | — | — | +0.6% | +3.1% | +2.7% | +2.8% | +2.6% | -0.4% | -0.7% | -0.9% | -0.2% | +7.9% | +7.0% | +7.6% | +8.4% | -1.9% | -73.5% | +1.1% | -73.4% | -1.8% | -73.5% |